LUCY Stock Analysis: Buy, Sell, or Hold?
LUCY - Innovative Eyewear, Inc. Common Stock
$0.68
0.00 (-0.09%)
âŧ
5d:
-6.85%
30d:
-1.64%
90d:
-30.99%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When LUCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LUCY is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LUCY is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LUCY is currently trading at $0.68, which is considered slightly low relative to its 30-day fair value range of $0.68 to $0.76.
Technical Outlook: Technically, LUCY is in a strong downtrend. The price is currently testing key support at $0.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LUCY scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+338.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LUCY is in a strong downtrend. The price is currently testing key support at $0.67. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LUCY scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+338.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.68 -
$0.76
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 338.7% below Wall St target ($3.00)
- WARNING: Composite score 31/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.68 -
$0.76
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$0.77
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.63
Wall Street Target
$3.00
(+338.7%)
Revenue Growth (YoY)
70.2%
Profit Margin
-272.5%
Share & Embed Analysis
Last updated: August 24, 2026 7:36 AM ET
Data refreshes hourly during market hours. Next update: 8:36 AM
Data refreshes hourly during market hours. Next update: 8:36 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 37 SELL |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
